Podcasts Other The Mike Hosking Breakfast Sarah Hogan: NZIER economist on research finding late prostate cancer diagnoses cost NZ $300 million over four years

Sarah Hogan: NZIER economist on research finding late prostate cancer diagnoses cost NZ $300 million over four years

Published: Sept. 13, 2022, 7:49 p.m.

New Zealand\u2019s terrible record when it comes to diagnosing prostate cancer is causing those who receive the diagnosis to lose hundreds of millions in earnings.

Research between the NZIER and Prostate Cancer Foundation found that on average, men who get a late diagnosis lose out on about $12,000 over four years.

While it might not seem like a huge amount, when you realise that almost 60 percent of cases are late diagnoses, it adds up to more than $300 million in reduced earnings over that four year period.

And compare that to catching it early - which means there is no loss of earnings.

NZIER principal economist Sarah Hogan did the research and Sarah joined Mike Hosking.

LISTEN ABOVE

See omnystudio.com/listener for privacy information.